Medical library access to UpToDate, Lexidrug and Epocrates: what your institution already licenses

The short answer: academic health sciences libraries and hospital systems commonly license UpToDate, Lexidrug, Micromedex or DynaMed for everyone affiliated with them, and access usually runs off campus through an institutional login such as EZproxy, OpenAthens or single sign-on. Before you pay for anything personally, check three places: your library's clinical resources page, the drug reference link inside your EHR medication activity, and your professional society, because ACP membership includes DynaMedex and that carries Micromedex drug content. Institutional access is tied to your affiliation, which means it ends the day you graduate or change employers.

This is the least glamorous money-saving advice in clinical software and one of the most reliable. A great many US clinicians and trainees pay every year for a subscription their institution already holds, usually because nobody told them it existed. Below is how the access actually works, how to check yours in about five minutes, and what to buy on the day it stops.

How does medical library access to UpToDate actually work?

The license is bought by the institution and authenticated against the institution, not against you. That single fact explains almost every confusing thing about it. You do not have a UpToDate account in the way you have a Netflix account; you have an affiliation that a proxy server vouches for.

In practice there are three doors. On campus or on the hospital network, the IP address alone is often enough, so the resource simply opens. Off campus, the library routes you through EZproxy or OpenAthens, which is why the working link is the one on the library's page rather than the vendor's homepage. Increasingly, health systems put it behind the same single sign-on as everything else, so it opens once you are logged into the institutional identity provider.

Mobile is where people get stuck. To use the app rather than the browser, most vendors want you to create a personal account while you are authenticated as an institutional user, which then licenses the app to you for a set period. After that period you have to reconfirm affiliation, usually by logging in again from inside the network or through the proxy. If your app has suddenly started asking you to subscribe, that reconfirmation window is the first thing to check, not your credit card.

Start at the library page, not the vendor page

The most common failure is going to the vendor's website, being asked for a subscription, and concluding your institution does not have it. The vendor site has no idea who you are. Search your institution's name plus the resource in your own library catalog, or open the health sciences library's databases or clinical resources page and find the resource there.

That is also why the searches people run in this area look the way they do. Queries pairing a university with a resource, the equivalent of asking for Lexicomp at USC or UpToDate at a named medical library, are overwhelmingly people looking for the correct authenticated door rather than people shopping. If that is you, the answer is nearly always the library's own link, and a medical librarian will send it to you the same day if you email and ask.

What do academic health sciences libraries usually license?

Collections vary by institution and by what the pharmacy department standardized on, but the shape is fairly consistent across US academic medical centers and teaching hospitals.

Notice which one is missing from the library shelf. Epocrates is an individual mobile app that happens to sell group tiers, and it does not fill the collection role a library is buying for. That distinction matters if you are the person making the recommendation, and it answers a question that gets asked more often than you would expect.

Is Epocrates or Lexicomp better in a medical academic library environment?

Lexidrug, and it is not close, but only because the question is about an institution rather than a clinician. A library buys for depth that supports pharmacy and clinical questions, for coverage its faculty and residents can cite, and for authentication that works reliably off campus for several thousand affiliated users at once. Lexidrug is designed and sold for exactly that, and it integrates into the EHR where the licensing supports it.

Epocrates is excellent at a different job. It is fast, it lives in a coat pocket, and its free tier answers a lot of ordinary questions. But its group subscriptions are tiered and quoted by license count, it is not a reference collection, and no library is going to build authentication around a consumer app store subscription. If you are choosing personally rather than institutionally, the calculus flips entirely, and our comparison of drug reference apps by role works through that version of the decision with every published US price.

Check your professional society before you buy anything

This is the route almost nobody checks and it is the strongest one available to an individual. The American College of Physicians includes DynaMedex free with membership. ACP describes it as delivering the clinical expertise and curated disease content of DynaMed with the comprehensive drug information of Micromedex in one place, with expanded drug monographs including Micromedex In-Depth Answers.

Read that carefully, because it is genuinely unusual. Micromedex publishes no list price and is sold to institutions, which means an individual clinician generally cannot buy it at all. Society membership is the one ordinary route to that content, and a lot of internists who pay ACP dues every year have never opened it.

What happens to your access when you graduate or change jobs

It stops, because it was never yours. Institutional licenses are counted and priced on affiliated users, so the moment your affiliation ends, so does the entitlement. Residents and fellows are hit hardest by this: you spend three to seven years building a workflow around a tool, and then the app asks you to subscribe in a week when you have just started a new job.

Handle it deliberately rather than reflexively. Before you renew or subscribe to anything, work out which resource you actually used and for what. The honest audit usually shows that most of the daily use was drug lookups, which the free options cover well, and that the deep reference was for a handful of harder questions a month. Then check whether the new employer licenses something, because a very large number of US hospitals do.

The same accounting problem runs in the other direction for the institution. Libraries and health systems pay for seats on user counts that drifted years ago, and finance departments renewing a stack of quoted contracts often cannot see which subscriptions the organization is actually paying for until somebody goes looking. That is why the counting question in a renewal is worth more attention than the negotiation that follows it.

Why you cannot find out what your library paid

Because no major vendor publishes institutional pricing, and your library is under no obligation to tell you. UpToDate, Micromedex and DynaMed are quoted per organization on user count, licensed beds, number of sites and contract term. UpToDate's own store will not show a figure until you have declared a country and a professional role, and it routes any organization with 20 or more users to enterprise sales.

The only published prices in this category are the individual ones: Lexidrug at $29.99 a month after a one-month trial, and epocrates+ at $179.99 a year or $24.99 a month, both verified on their US App Store listings in August 2026. Medscape and OpenEvidence cost nothing. Software directories will happily quote you an annual institutional figure, and those figures contradict each other by hundreds of dollars for the same product, so do not build a budget on one. If you are the person running the purchase, our guide to institutional and group license pricing covers what actually moves a quote and the questions that get comparable numbers out of vendors.

What a library license does not cover

Access is not the same as coverage, and this is where the money question turns into a clinical one. A reference answers what you ask it. The interaction that reaches a patient is very rarely the one somebody suspected and looked up; it is the one nobody had a reason to check. Adding a second licensed reference to the collection does not change that, which is why institutions with excellent libraries still have prescribing safety problems.

The other gap is shape. A real prescribing decision is usually blocked by several things at once: an interaction, plus a renal dose that needs adjusting, plus an allergy nobody flagged, plus a drug-disease contraindication sitting in the problem list. Checking all four in a reference means four lookups, and on a busy service the fourth one does not happen. That is a workflow problem rather than a licensing problem, and it is the reason clinical decision support is treated as a category separate from reference.

A five-minute check, in order

Do these before you spend anything.

One. Open your health sciences library's clinical resources page and look for UpToDate, Lexidrug, Micromedex and DynaMed. Use the library's link, not the vendor's site.

Two. Open your EHR, go into the medication activity, and look for a drug reference link. In a large number of US hospitals that is Lexidrug, licensed and paid for already.

Three. Check your professional society. ACP membership includes DynaMedex. Other societies bundle references too, and almost nobody reads the benefits list.

Four. Email a medical librarian. This costs one message and is the single highest-yield step on the list, because finding out what an institution licenses is literally their job.

Five. Only then decide what gap is left, and buy against that specific gap rather than against a general feeling that you should own a drug app.

Where this leaves you

If you have institutional access, use it and stop paying twice. If you are about to lose it, audit what you genuinely used before you replace it, because the replacement is usually smaller and cheaper than the thing you had. If you are buying for a group, the published individual prices on this page are the only benchmark you will ever get for free, and everything else has to come out of parallel quotes at your exact headcount.

And whichever reference sits behind your institution's login, the checks still have to happen before you sign. Prescriber.io runs the interaction check, contraindication and allergy flags, renal and hepatic dose adjustments and guideline-based alternatives together in one card, with sources cited on each flag. It checks and suggests; a licensed clinician verifies against official sources and decides.